Oragenics, Inc. (NYSE: OGEN), a biotechnology company advancing innovative treatments for brain-related health conditions, today announced the conversion of its remaining outstanding convertible ...
CHENNAI: Trauma, attachment styles, repression — these buzzwords teem in online discourse, inexplicably altering our ideas of how we view ourselves and the worl ...
Alpha Cognition Inc. (Nasdaq: ACOG) (CSE: ACOG) (“Alpha Cognition” [ACI], or the “Company”), a biopharmaceutical company developing novel therapies fo ...